| For: | Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16(15): 1832-1836 [PMID: 20397259 DOI: 10.3748/wjg.v16.i15.1832] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1832.htm |
| Number | Citing Articles |
| 1 |
James Sligh, Jaroslav Janda, Jana Jandova. Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2014; 769 doi: 10.1016/j.mrfmmm.2014.07.003
|
| 2 |
Yin Xia, Linlin Zhou, Hung-Chih Yang, Chen-Wei Yu. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance. International Immunopharmacology 2022; 113 doi: 10.1016/j.intimp.2022.109372
|
| 3 |
Antonio Solinas, Diego F Calvisi. Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas. World Journal of Gastroenterology 2015; 21(12): 3472-3479 doi: 10.3748/wjg.v21.i12.3472
|
| 4 |
Lorenzo A. Orci, Stéphanie Lacotte, Graziano Oldani, Philippe Morel, Gilles Mentha, Christian Toso. The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence. Digestive Diseases and Sciences 2014; 59(9) doi: 10.1007/s10620-014-3182-7
|
| 5 |
Carmen Berasain, María Ujue Latasa, Raquel Urtasun, Saioa Goñi, María Elizalde, Oihane Garcia-Irigoyen, María Azcona, Jesús Prieto, Matías A. Ávila. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers 2011; 3(2) doi: 10.3390/cancers3022444
|
| 6 |
Olaia Martínez-Iglesias, Elvira Alonso-Merino, Ana Aranda. Tumor suppressive actions of the nuclear receptor corepressor 1. Pharmacological Research 2016; 108 doi: 10.1016/j.phrs.2016.04.027
|
| 7 |
Wan Liu, Wenjing Wang, Xinran Wang, Cong Xu, Ning Zhang, Wen Di. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Cancer Letters 2020; 472 doi: 10.1016/j.canlet.2019.12.024
|
| 8 |
Anupam Bishayee. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816 doi: 10.1007/978-3-0348-0837-8_16
|
| 9 |
Jakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska, Paweł Knapp. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer. Molecules 2022; 27(7) doi: 10.3390/molecules27072041
|
| 10 |
Junwei Han, Siyao Liu, Yunpeng Zhang, Yanjun Xu, Ying Jiang, Chunlong Zhang, Chunquan Li, Xia Li. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs. Oncotarget 2016; 7(34) doi: 10.18632/oncotarget.10839
|
| 11 |
Yidi Sun. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1). Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1183795
|
| 12 |
Burcu Sengez, Brian I. Carr, Hani Alotaibi. EMT and Inflammation: Crossroads in HCC. Journal of Gastrointestinal Cancer 2023; 54(1) doi: 10.1007/s12029-021-00801-z
|
| 13 |
Xinjie Lu. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1
in Cancer. Current Medicinal Chemistry 2022; 29(41) doi: 10.2174/0929867329666220629140540
|
| 14 |
Ke‐qi Han, Hui Han, Xue‐qun He, Lei Wang, Xiao‐dong Guo, Xue‐ming Zhang, Jie Chen, Quan‐gang Zhu, Hua Nian, Xiao‐feng Zhai, Ma‐wei Jiang. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma. Cancer Medicine 2016; 5(10) doi: 10.1002/cam4.843
|
| 15 |
Zhitao Zhou, Xiao Lu, Ping Zhu, Wei Zhu, Xia Mu, Rongmei Qu, Ming Li. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Biochemical and Biophysical Research Communications 2012; 420(2) doi: 10.1016/j.bbrc.2012.02.160
|
| 16 |
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020; 41(12) doi: 10.1093/carcin/bgaa106
|
| 17 |
Hacer Sahin, Christian Trautwein, Hermann E. Wasmuth. Functional role of chemokines in liver disease models. Nature Reviews Gastroenterology & Hepatology 2010; 7(12) doi: 10.1038/nrgastro.2010.168
|
| 18 |
QUANCHI CHEN, WEI SUN, YUXIN LIAO, HUI ZENG, LIANCHENG SHAN, FEI YIN, ZHUOYING WANG, ZIFEI ZHOU, YINGQI HUA, ZHENGDONG CAI. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT. Molecular Medicine Reports 2015; 12(1) doi: 10.3892/mmr.2015.3375
|
| 19 |
Chunyan Li, Dong Kang, Xiguang Sun, Yufei Liu, Jinhong Wang, Pujun Gao. The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling. BioMed Research International 2015; 2015 doi: 10.1155/2015/345413
|
| 20 |
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells. Nutrition and Cancer 2013; 65(4) doi: 10.1080/01635581.2013.770043
|
| 21 |
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Journal of Histochemistry & Cytochemistry 2019; 67(5) doi: 10.1369/0022155418824274
|
| 22 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054286
|
| 23 |
Ahmed Tawheed, Abdulla A. Mahmoud, Hussein Hassan Aly, Mohamed El-Kassas. Coexistent Hepatitis B Virus and Metabolic Dysfunction-Associated Steatotic Liver Disease Under the New Definition: A New Era for Established Diseases. Livers 2026; 6(3) doi: 10.3390/livers6030044
|
| 24 |
Wen‐Hsiu Hsu, Cheng‐Nan Chen, Hai‐I Huang, Yi‐Liang Lai, Chun‐Yuh Teng, Wu‐Hsien Kuo. Urokinase induces stromal cell‐derived factor‐1 expression in human hepatocellular carcinoma cells. Journal of Cellular Physiology 2012; 227(2) doi: 10.1002/jcp.22777
|
| 25 |
Qiaofei Liu, Aiqun Zhang, Wenli Xu, Jiahong Dong. A new view of the roles of blood flow dynamics and Kupffer cell in intra-hepatic metastasis of hepatocellular carcinoma. Medical Hypotheses 2011; 77(1) doi: 10.1016/j.mehy.2011.03.033
|
| 26 |
Christian Breunig, Bernadett J. Mueller, Ludmila Umansky, Kristin Wahl, Katrin Hoffmann, Frank Lehner, Michael P. Manns, Heike Bantel, Christine S. Falk. BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma. Clinical Cancer Research 2014; 20(9) doi: 10.1158/1078-0432.CCR-13-1635
|
| 27 |
Justin Monnier, Mathieu Boissan, Annie L’Helgoualc’h, Marie-Lise Lacombe, Bruno Turlin, Jessica Zucman-Rossi, Nathalie Théret, Claire Piquet-Pellorce, Michel Samson. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. European Journal of Cancer 2012; 48(1) doi: 10.1016/j.ejca.2011.06.044
|
| 28 |
Jialiang Wang, Xiaoyu Zhang, Xinyi Ma, Dongmei Chen, Meina Cai, Lexin Xiao, Jing Li, Zexuan Huang, Yuehua Huang, Yifan Lian. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02885-w
|
| 29 |
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. Medical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
|
| 30 |
Gang Han, Dawei Wu, Yongan Yang, Zhiyun Li, Jiapin Zhang, Chengjun Li. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer. Cytokine 2015; 76(2) doi: 10.1016/j.cyto.2015.05.009
|
| 31 |
Marie Anson, Anne-Marie Crain-Denoyelle, Véronique Baud, Fanny Chereau, Angélique Gougelet, Benoit Terris, Satoshi Yamagoe, Sabine Colnot, Mireille Viguier, Christine Perret, Jean-Pierre Couty. Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. Journal of Clinical Investigation 2012; 122(2) doi: 10.1172/JCI43937
|
| 32 |
Olaia A. Martínez-Iglesias, Elvira Alonso-Merino, Sara Gómez-Rey, Juan Pedro Velasco-Martín, Rosa Martín Orozco, Enrique Luengo, Rosa García Martín, Inmaculada Ibáñez de Cáceres, Agustín F. Fernández, Mario F. Fraga, Pilar González-Peramato, Constantino Varona, José Palacios, Javier Regadera, Ana Aranda. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis. Proceedings of the National Academy of Sciences 2016; 113(3) doi: 10.1073/pnas.1520469113
|
| 33 |
AW Wahid Ansari, Reinhold E Schmidt, Esaki M Shankar, Adeeba Kamarulzaman. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0341-8
|
| 34 |
Imene Ben Dhifallah, Kaouther Ayouni, Zeineb Belaiba, Bacem AlaDdine Razgui, Sahar Trabelsi, Henda Touzi, Amel Sadraoui, Walid Hammemi, Hela Hannachi, Amira Kebir, Slimane Ben Miled, Henda Triki. Role of Common Fractalkine Receptor Variants with Chronic Hepatitis B Patients in Tunisia. Viruses 2025; 17(7) doi: 10.3390/v17070968
|
| 35 |
Bosheng He, Ying He, Weixiang Shi, Shenchu Gong, Xiaohong Chen, Jing Xiao, Jinhua Gu, Wenbin Ding, Yilang Wang. Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma. Molecular Medicine Reports 2017; 15(6) doi: 10.3892/mmr.2017.6445
|
| 36 |
S. Costantini, G. Di Bernardo, M. Cammarota, G. Castello, G. Colonna. Gene expression signature of human HepG2 cell line. Gene 2013; 518(2) doi: 10.1016/j.gene.2012.12.106
|
| 37 |
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23168846
|
| 38 |
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1) doi: 10.1038/cmi.2013.37
|
| 39 |
Maria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, Nunzia Simona Losito, Maria Napolitano, Luigi Portella, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Trotta, Steven Curley, Susan Costantini, Raffaele Liuzzi, Francesco Izzo, Stefania Scala. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not. Cellular & Molecular Immunology 2015; 12(4) doi: 10.1038/cmi.2014.102
|
| 40 |
Xiao-Lan Wei, Jing Zhang, Zhi-Hong Mo. Regulation of chemokine receptor CXCR4 in HepG2 cell adhesion sensing by QCM. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; doi: 10.1109/HHBE.2011.6029075
|
| 41 |
Siti A Sulaiman, Nadiah Abu, Nurul-Syakima Ab-Mutalib, Teck Yew Low, Rahman Jamal. Signatures of Gene Expression, DNA Methylation and microRNAs of Hepatocellular Carcinoma with Vascular Invasion. Future Oncology 2019; 15(22) doi: 10.2217/fon-2018-0909
|
| 42 |
Christian Stock. From Malignant Transformation to Metastasis. Reviews of Physiology, Biochemistry and Pharmacology 2021; 182 doi: 10.1007/112_2021_68
|
| 43 |
Chang-Xian Li, Kwan Man, Chung-Mau Lo. The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation. Transplantation 2017; 101(11) doi: 10.1097/TP.0000000000001844
|
| 44 |
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, Ayana. R. Kumar, Benjamin S. Meyer, Arun Valsan, Vinod Vijayakurup, Lekshmi R. Nath. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma. Molecular Biotechnology 2024; 66(10) doi: 10.1007/s12033-023-00890-0
|
| 45 |
Sen-Sen LIN, Fang-Fang LI, Li SUN, Wei FAN, Ming GU, Lu-Yong ZHANG, Song QIN, Sheng-Tao YUAN. Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAK. Chinese Journal of Natural Medicines 2016; 14(3) doi: 10.1016/S1875-5364(16)30017-6
|
| 46 |
Kanjoormana Aryan Manu, Muthu K. Shanmugam, Tina H. Ong, Aruljothi Subramaniam, Kodappully Sivaraman Siveen, Ekambaram Perumal, Ramar Perumal Samy, Pradeep Bist, Lina H. K. Lim, Alan Prem Kumar, Kam M. Hui, Gautam Sethi, Kwan Man. Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma. PLoS ONE 2013; 8(3) doi: 10.1371/journal.pone.0057015
|
| 47 |
Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien‐jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei‐Hsuan Lee, Hwai‐I Yang. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individuals. Alimentary Pharmacology & Therapeutics 2021; 54(6) doi: 10.1111/apt.16524
|
| 48 |
Weilong Chen, Yuanyuan Qin, Suling Liu. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1231 doi: 10.1007/978-3-030-36667-4_6
|
| 49 |
Ken Shirabe, Takashi Motomura, Jun Muto, Takeo Toshima, Rumi Matono, Yohei Mano, Kazuki Takeishi, Hideki Ijichi, Noboru Harada, Hideaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Yoshihiko Maehara. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management. International Journal of Clinical Oncology 2010; 15(6) doi: 10.1007/s10147-010-0131-0
|
| 50 |
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012 doi: 10.1155/2012/684802
|
| 51 |
Yasuteru Kondo, Osamu Kimura, Yasuhito Tanaka, Masashi Ninomiya, Tomoaki Iwata, Takayuki Kogure, Jun Inoue, Masaya Sugiyama, Tatsuki Morosawa, Yasuyuki Fujisaka, Tooru Shimosegawa, J.-H. J. Ou.
Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1
+
Immune Cells
. Journal of Virology 2015; 89(14) doi: 10.1128/JVI.00716-15
|
| 52 |
Feng Xue, Brandon W. Higgs, Jiaqi Huang, Chris Morehouse, Wei Zhu, Xin Yao, Philip Brohawn, Zhan Xiao, Yinong Sebastian, Zheng Liu, Yun Xia, Dong Shen, Mike Kuziora, Zhengwei Dong, Hulin Han, Yi Gu, Jianren Gu, Qiang Xia, Yihong Yao. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0743-2
|
| 53 |
Li Li, Jing Yan, Jing Xu, Chao-Qun Liu, Zuo-Jun Zhen, Huan-Wei Chen, Yong Ji, Zhi-Peng Wu, Jian-Yuan Hu, Limin Zheng, Wan Yee Lau, Cordula M. Stover. CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0110064
|
| 54 |
Hiroshi Miyazaki, Kazuaki Takabe, W Andrew Yeudall. Chemokines, chemokine receptors and the gastrointestinal system. World Journal of Gastroenterology 2013; 19(19): 2847-2863 doi: 10.3748/wjg.v19.i19.2847
|
| 55 |
Ho-Sung Lee, In-Hee Lee, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee, Bashar Saad. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/5765233
|
| 56 |
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. The CCL20-CCR6 Axis in Cancer Progression. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155186
|
| 57 |
Chiara Taibi, Laura Vincenzi, Gianpiero D’Offizi. Hepatocellular Carcinoma. Updates in Surgery 2023; doi: 10.1007/978-3-031-09371-5_3
|
| 58 |
Rim Serhal, George Hilal, George Boutros, Joseph Sidaoui, Layal Wardi, Salah Ezzeddine, Nada Alaaeddine. Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators. BioMed Research International 2015; 2015 doi: 10.1155/2015/850246
|